Baqsimi™ (glucagon) nasal poweder 3mg
  • Patients and Caregivers Home
    • What is BAQSIMI?
    • When to use BAQSIMI?
    • How to use BAQSIMI?
    • BAQSIMI basics
  • For Healthcare Providers
    • Pediatric Patients Home
      Pediatric Patients Home
      • Efficacy
      • Safety
      • Administration/Usage
      • MoA
    • Adult Patients Home
      Adult Patients Home
      • Efficacy
      • Safety
      • Administration
      • MoA
    • BAQSIMI Product Monograph
    • Severe Hypoglycemia Information
  • Got Your BAQ™ Resources
    • Initiation Guide
    • Expiration Reminder Tool
    • BAQ to school
Globe Loading... Reveal available languages

Got your BAQ resources

Watch the following video to learn how to administer BAQSIMI. Share it with your family, friends or coworkers so they can administer BAQSIMI in case of emergency.

Instructions for Use Video - English
1:04:59

BAQSIMI Initiation Guide

Prepare yourself, family, friends, and co-workers with all the information needed on how and when to use Baqsimi, with our getting started guide. This file can be saved to your phone/computer, printed, or shared.

Download in multiple languages below:

English Download PDF
French Download PDF
Simplified Chinese Download PDF
Punjabi Download PDF

BAQSIMI Expiration Reminder Tool

Use our Expiration Reminder Tool to get a reminder 3 and 1 month(s) prior, and on the day your BAQSIMI expires, by e-mail and/or text. Call your healthcare professional or visit your pharmacist at that time to refill your prescription.

Step 1: Name your BAQSIMI

Step 2: Select the expiry date on the tube of your BAQSIMI

Step 3: Enter contact information and preference

By clicking Submit, I acknowledge and agree to the Terms of Use and Privacy Statement for this site.

BAQ To School

Download the Baqsimi Poster to hang up in the classroom and let school staff and classmates be aware of the signs and symptoms of Severe Hypoglycemia, how to use Baqsimi, and where you carry your Baqsimi.

Download in multiple languages below:

English Download PDF
French Download PDF

Clinical use:
BAQSIMI has not been studied in pediatric patients less than 4 years old.

Limited clinical trial experience has not identified difference in responses between elderly (≥65 years of age) and younger patients.



Contraindications:

  • Hypersensitivity to glucagon or to any ingredient in the formulation or container
  • Pheochromocytoma
  • Insulinoma



Most serious warnings and precautions:
Lack of response: BAQSIMI should be given only in patients where impaired consciousness precludes oral carbohydrates. After intranasal administration of BAQSIMI, the patient will normally respond within 15 minutes. If the patient does not respond within 15 minutes, intravenous glucose must be administered as soon as possible.

States of starvation, adrenal insufficiency or chronic hypoglycemia: Because glucagon is of little or no help in these cases, intravenous glucose should be used for the treatment of hypoglycemia in these conditions.



Other relevant warnings and precautions:

  • Cardiovascular effects
  • Driving and operating machinery
  • Pheochromocytoma
  • Insulinoma
  • Sensitivity and resistance to glucagon
  • Pregnant women
  • Breast-feeding
  • Pediatrics (<4 years of age)
  • Geriatrics (>65 years of age)
  • Use in patients with Type 2 diabetes taking sulfonylureas
  • Use with alcohol
  • Monitoring and laboratory tests



For more information:
Consult the product monograph at http://pi.lilly.com/ca/baqsimi-ca-pm.pdf for additional important information relating to warnings and precautions, adverse reactions, drug interactions and dosing information which have not been discussed in this piece. The product monograph is also available by calling 1-888-545-5972.

Privacy
Terms of Use
Disclaimer
Accessibility
Site map
 

BAQSIMI® is a trademark owned by or licensed to Eli Lilly and Company, its subsidiaries or affiliates.



PP-GN-CA-0018 01/2020 © Eli Lilly Canada Inc. 2020

Privacy Terms of Use Disclaimer Accessibility Site map
Member of Innovative Medicines Canada
Lilly